0001104659-24-008796.txt : 20240131
0001104659-24-008796.hdr.sgml : 20240131
20240131161047
ACCESSION NUMBER: 0001104659-24-008796
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240130
FILED AS OF DATE: 20240131
DATE AS OF CHANGE: 20240131
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HEALY JAMES
CENTRAL INDEX KEY: 0001245624
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41929
FILM NUMBER: 24582999
MAIL ADDRESS:
STREET 1: 3000 SAND HILL ROAD, 4-250
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ArriVent Biopharma, Inc.
CENTRAL INDEX KEY: 0001868279
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 18 CAMPUS BLVD.
STREET 2: SUITE 100
CITY: NEWTOWN SQUARE
STATE: PA
ZIP: 19073-3269
BUSINESS PHONE: 240-780-6356
MAIL ADDRESS:
STREET 1: 18 CAMPUS BLVD.
STREET 2: SUITE 100
CITY: NEWTOWN SQUARE
STATE: PA
ZIP: 19073-3269
4
1
tm244611-2_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-01-30
0
0001868279
ArriVent Biopharma, Inc.
AVBP
0001245624
HEALY JAMES
C/O ARRIVENT BIOPHARMA, INC.
18 CAMPUS BOULEVARD, SUITE 100
NEWTOWN SQUARE
PA
19073
1
0
0
0
0
Common Stock
2024-01-30
4
C
0
1252308
A
1252308
I
Sofinnova Venture Partners XI, L.P.
Common Stock
2024-01-30
4
P
0
444444
18.00
A
1696752
I
Sofinnova Venture Partners XI, L.P.
Series B Preferred Stock
2024-01-30
4
C
0
1252308
D
Common Stock
1252308
0
I
Sofinnova Venture Partners XI, L.P.
The shares of preferred stock automatically converted into common stock immediately upon completion of the Issuer's initial public offering on a 1-for-15.21 basis.
The shares are directly held by Sofinnova Venture Partners XI, L.P. ("SVP XI"). Sofinnova Management XI, L.P. ("SM XI LP") is the general partner of SVP XI and Sofinnova Management XI, L.L.C. ("SM XI") is the general partner of SM XI LP. The Reporting Person is a managing member of SM XI and may be deemed to share voting and dispositive power over the shares held by SVP XI. The Reporting Person disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein.
Reflects shares purchased in the Issuer's initial public offering.
The shares of preferred stock were convertible into the Issuer's common stock in accordance with the Issuer's Restated Certificate of Incorporation, as amended, immediately upon completion of the Issuer's initial public offering.
Not applicable.
/s/ James Kastenmayer, Attorney-in-Fact for James Healy
2024-01-31